Alterity Therapeutics Limited (ASX:ATH)

Alterity Therapeutics Cash Flow Statement

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Operating Cash Flow	-13.7	-11.45	-12.61	-20.04	-12.34	-17.33
Capital Expenditures	-	-	-0.01	-0.01	-0.09	-0.01
Purchases of Investments	-	-7.5	-	-	-	-
Other Investing Activities	-	-	-	-0.03	-	-
Investing Cash Flow	-	-7.5	-0.01	-0.04	-0.09	-0.01
Issuance of Common Stock	61.63	42.57	10.14	0.32	17.18	39.24
Net Common Stock Issued (Repurchased)	61.63	42.57	10.14	0.32	17.18	39.24
Other Financing Activities	-3.06	-2.9	-0.93	-0.19	-0.87	-2.55
Financing Cash Flow	58.57	39.67	9.22	0.12	16.3	36.69
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.22	-0.2	0.26	0.91	2.81	-0.43
Net Cash Flow	44.65	20.72	-3.4	-19.95	3.88	19.35
Free Cash Flow	-12.97	-11.45	-12.61	-20.04	-12.43	-17.34
Free Cash Flow Per Share	-0.88	-1.07	-2.07	-4.95	-3.10	-6.13
Levered Free Cash Flow	-14.59	-12.15	-19.13	-13.81	-12.94	-15.32
Unlevered Free Cash Flow	15.98	20.21	23.68	18.7	20.65	19.57

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.